Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Clinical chemistry of human FcRn transgenic mice.
Mamm. Genome 23, 259-269 (2012)
Mice genetically engineered to express human FcRn are valuable models for the evaluation of therapeutic antibodies in the context of human FcRn in vivo. However, only limited clinical chemistry information on these mouse strains is available. Thus, we have compared 30 clinical chemical parameters of C57BL/6J wild-type mice, murine FcRn-knockout mice, and two human FcRn transgenic mouse strains expressing human FcRn in the absence of murine FcRn. Since FcRn-mediated recycling prevents albumin and IgG from intracellular degradation, significant differences for both proteins were observed in the murine FcRn-knockout mice. Mice lacking FcRn show lower IgG and albumin levels compared to wild-type mice. The most prominent differences in clinical chemical parameters can be explained by secondary effects of the altered albumin levels of murine FcRn-knockout mice on liver metabolism, as similar tendencies have been observed in analbuminemic Nagase rats and hypoalbuminemic human patients, showing an overall increased liver metabolism. Both human FcRn transgenic strains show clinical chemical parameters similar to those found for wild-type mice, with the exception of endogenous IgG levels, which are greatly reduced in these mice.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
2.887
0.755
26
27
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
NAGASE ANALBUMINEMIC RATS; THERAPEUTIC ANTIBODIES; HALF-LIFE; CONGENITAL ANALBUMINEMIA; NEPHROTIC SYNDROME; IGG HOMEOSTASIS; PLASMA-PROTEINS; TOTAL CALCIUM; ALBUMIN GENE; SERUM
Sprache
Veröffentlichungsjahr
2012
HGF-Berichtsjahr
2012
ISSN (print) / ISBN
0938-8990
e-ISSN
1432-1777
Zeitschrift
Mammalian Genome
Quellenangaben
Band: 23,
Heft: 3-4,
Seiten: 259-269
Verlag
Springer
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Experimental Genetics (IEG)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-500600-003
G-500600-001
G-500600-001
PubMed ID
22193411
WOS ID
WOS:000301304600004
Scopus ID
84862638874
Erfassungsdatum
2012-03-23